AMS — Advanced Medical Solutions Income Statement
0.000.00%
Last trade - 00:00- £389.48m
- £338.45m
- £126.21m
- 73
- 22
- 79
- 61
Annual income statement for Advanced Medical Solutions, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 102 | 86.8 | 109 | 124 | 126 |
| Cost of Revenue | |||||
| Gross Profit | 60.5 | 46 | 61.1 | 73.4 | 70.1 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 78.1 | 76.1 | 85.6 | 99.4 | 107 |
| Operating Profit | 24.2 | 10.7 | 23 | 24.9 | 18.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 24.3 | 10.1 | 22 | 25.9 | 21.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 18.9 | 8.58 | 17.5 | 20.4 | 15.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 18.9 | 8.58 | 17.5 | 20.4 | 15.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 18.9 | 8.58 | 17.5 | 20.4 | 15.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.091 | 0.043 | 0.08 | 0.093 | 0.072 |
| Dividends per Share |